The DOI matches its Crossref record; 198 of the 206 references it cites were found in a registry or an index.
Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?
Open accessAbstract
Colorectal cancer (CRC) is a predominant malignancy worldwide, being the fourth most common cause of mortality and morbidity. The CRC incidence in adolescents, young adults, and adult populations is increasing every year. In the pathogenesis of CRC, various factors are involved including diet, sedentary life, smoking, excessive alcohol consumption, obesity, gut microbiota, diabetes, and genetic mutations. The CRC tumor microenvironment (TME) involves the complex cooperation between tumoral cells with stroma, immune, and endothelial cells. Cytokines and several growth factors (GFs) will sustain CRC cell proliferation, survival, motility, and invasion. Epidermal growth factor receptor (EGFR), Insulin-like growth factor -1 receptor (IGF-1R), and Vascular Endothelial Growth Factor -A (VEGF-A) are overexpressed in various human cancers including CRC. The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) and all the three major subfamilies of the mitogen-activated protein kinase (MAPK) signaling pathways may be activated by GFs and will further play key roles in CRC development. The main aim of this review is to present the CRC incidence, risk factors, pathogenesis, and the impact of GFs during its development. Moreover, the article describes the relationship between EGF, IGF, VEGF, GFs inhibitors, PI3K/AKT/mTOR-MAPK signaling pathways, and CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Increased levels of cytokines and growth factors in the TME can activate cell proliferation and survival signaling pathways in CRC cells (e.g., MAPK and PI3K/AKT) [84].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [84]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Lin, X., Wang, S., Sun, M., Zhang, C., Wei, C., Yang, C., Dou, R., Liu, Q., & Xiong, B. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0708-7 · Cited by 207
RetractedZhang, D., Qiu, X., Li, J., Zheng, S., Li, L., & Zhao, H. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1556064 · Cited by 72
RetractedBrenner, H., Kloor, M., & Pox, C. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61649-9 · Cited by 2,762
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
Colorectal cancer statistics, 2014
Siegel, R., DeSantis, C., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21220 · Cited by 2,562
Pathological roles of MAPK signaling pathways in human diseases
Kim, E. K., & Choi, E.-J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.009 · Cited by 2,472
Kuipers, E. J., Grady, W. M., Lieberman, D., Seufferlein, T., Sung, J. J., Boelens, P. G., van de Velde, C. J. H., & Watanabe, T. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.65 · Cited by 1,563
Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
Aggarwal, V., Tuli, H., Varol, A., Thakral, F., Yerer, M., Sak, K., Varol, M., Jain, A., Khan, M., & Sethi, G. (2019) · Biomolecules · doi:10.3390/biom9110735 · Cited by 1,221
The MAPK signalling pathways and colorectal cancer
Fang, J. Y., & Richardson, B. C. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70168-6 · Cited by 1,185
Microsatellite Instability in Colorectal Cancer-the Stable Evidence
Vilar, E., & Gruber, S. B. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.237 · Cited by 1,063
Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer
Yaeger, R., Chatila, W. K., Lipsyc, M. D., Hechtman, J. F., Cercek, A., Sanchez-Vega, F., Jayakumaran, G., Middha, S., Zehir, A., Donoghue, M. T. A., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2017.12.004 · Cited by 858
Bardou, M., Barkun, A. N., & Martel, M. (2013) · Gut · doi:10.1136/gutjnl-2013-304701 · Cited by 815
Smoking and Colorectal Cancer: A Meta-analysis
Botteri, E., Iodice, S., Bagnardi, V., Raimondi, S., Lowenfels, A. B., & Maisonneuve, P. (2008) · JAMA · doi:10.1001/jama.2008.839 · Cited by 778
Pearlman, R., Frankel, W. L., Swanson, B., Zhao, W., Yilmaz, A., Miller, K., Bacher, J., Bigley, C., Nelsen, L., Goodfellow, P. J., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5194 · Cited by 707
Nutrients, foods, and colorectal cancer prevention
Song, M., Garrett, W. S., & Chan, A. T. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.12.035 · Cited by 700
Colorectal cancer development and advances in screening
Balchen, V., & Simon, K. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s109285 · Cited by 665
Early‐onset colorectal cancer in young individuals
Mauri, G., Sartore‐Bianchi, A., Russo, A., Marsoni, S., Bardelli, A., & Siena, S. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12417 · Cited by 634
Colorectal cancer population screening programs worldwide in 2016: An update
Navarro, M., Nicolas, A., Ferrandez, A., & Lanas, A. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i20.3632 · Cited by 611
Meric-Bernstam, F., Hurwitz, H., Raghav, K. P. S., McWilliams, R. R., Fakih, M., VanderWalde, A., Swanton, C., Kurzrock, R., Burris, H., Sweeney, C., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30904-5 · Cited by 573
Triantafillidis, J. K., Nasioulas, G., & Kosmidis, P. (2009) · PubMed · Cited by 559
Sandhu, M. S. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.13.972 · Cited by 496
Sex- and gender-specific disparities in colorectal cancer risk
Kim, S.-E. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i17.5167 · Cited by 493
Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer
Carethers, J. M., & Jung, B. H. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.047 · Cited by 483
Molecular pathological classification of colorectal cancer
Müller, M. F., Ibrahim, A. E. K., & Arends, M. J. (2016) · Virchows Archiv · doi:10.1007/s00428-016-1956-3 · Cited by 432
Li, J., Qin, S., Xu, R.-H., Shen, L., Xu, J., Bai, Y., Yang, L., Deng, Y., Chen, Z.-D., Zhong, H., et al. (2018) · JAMA · doi:10.1001/jama.2018.7855 · Cited by 425
Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances
Lech, G. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i5.1745 · Cited by 419
Therkildsen, C., Bergmann, T. K., Henrichsen-Schnack, T., Ladelund, S., & Nilbert, M. (2014) · Acta Oncologica · doi:10.3109/0284186x.2014.895036 · Cited by 390
Metabolic Pathways Regulating Colorectal Cancer Initiation and Progression
La Vecchia, S., & Sebastián, C. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.05.018 · Cited by 349
Zhang, R., Qi, F., Zhao, F., Li, G., Shao, S., Zhang, X., Yuan, L., & Feng, Y. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1435-2 · Cited by 343
Molecular epidemiology and diagnostics of KRAS mutations in human cancer
Timar, J., & Kashofer, K. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09915-5 · Cited by 334
Treatment sequencing in metastatic colorectal cancer
Modest, D. P., Pant, S., & Sartore-Bianchi, A. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2018.12.019 · Cited by 329
SMAD2,SMAD3 and SMAD4 Mutations in Colorectal Cancer
Fleming, N. I., Jorissen, R. N., Mouradov, D., Christie, M., Sakthianandeswaren, A., Palmieri, M., Day, F., Li, S., Tsui, C., Lipton, L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2706 · Cited by 324
Mechanisms of resistance to anti-EGFR therapy in colorectal cancer
Zhao, B., Wang, L., Qiu, H., Zhang, M., Sun, L., Peng, P., Yu, Q., & Yuan, X. (2017) · Oncotarget · doi:10.18632/oncotarget.14012 · Cited by 319
Microbiota, Inflammation and Colorectal Cancer
Lucas, C., Barnich, N., & Nguyen, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061310 · Cited by 313
Diet and colorectal cancer in UK Biobank: a prospective study
Bradbury, K. E., Murphy, N., & Key, T. J. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyz064 · Cited by 280
Granados-Romero, J. J., Valderrama-Treviño, A. I., Contreras-Flores, E. H., Barrera-Mera, B., Herrera Enríquez, M., Uriarte-Ruíz, K., Ceballos-Villalba, J. C., Estrada-Mata, A. G., Alvarado Rodríguez, C., & Arauz-Peña, G. (2017) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20174914 · Cited by 279
The association of diet, gut microbiota and colorectal cancer: what we eat may imply what we get
Yang, J., & Yu, J. (2018) · Protein & Cell · doi:10.1007/s13238-018-0543-6 · Cited by 275
Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer
Bultman, S. J. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500902 · Cited by 265
Bellido, F., Pineda, M., Aiza, G., Valdés-Mas, R., Navarro, M., Puente, D. A., Pons, T., González, S., Iglesias, S., Darder, E., et al. (2016) · Genetics in Medicine · doi:10.1038/gim.2015.75 · Cited by 265
Roles of circRNAs in the tumour microenvironment
Zhang, Q., Wang, W., Zhou, Q., Chen, C., Yuan, W., Liu, J., Li, X., & Sun, Z. (2020) · Molecular Cancer · doi:10.1186/s12943-019-1125-9 · Cited by 260
Narayanankutty, A. (2019) · Current Drug Targets · doi:10.2174/1389450120666190618123846 · Cited by 255
van Geel, R. M. J. M., Tabernero, J., Elez, E., Bendell, J. C., Spreafico, A., Schuler, M., Yoshino, T., Delord, J.-P., Yamada, Y., Lolkema, M. P., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0795 · Cited by 232
Connell, L. C., Mota, J. M., Braghiroli, M. I., & Hoff, P. M. (2017) · Current Treatment Options in Oncology · doi:10.1007/s11864-017-0463-3 · Cited by 229
Martinelli, E., Ciardiello, D., Martini, G., Troiani, T., Cardone, C., Vitiello, P. P., Normanno, N., Rachiglio, A. M., Maiello, E., Latiano, T., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2019.10.007 · Cited by 225
Role of Physical Activity and Diet After Colorectal Cancer Diagnosis
Van Blarigan, E. L., & Meyerhardt, J. A. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7799 · Cited by 222
Baena, R., & Salinas, P. (2015) · Maturitas · doi:10.1016/j.maturitas.2014.12.017 · Cited by 219
p38α MAPK pathway: A key factor in colorectal cancer therapy and chemoresistance
Grossi, V. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.9744 · Cited by 214
The Rise of Colorectal Cancer in Asia: Epidemiology, Screening, and Management
Onyoh, E. F., Hsu, W.-F., Chang, L.-C., Lee, Y.-C., Wu, M.-S., & Chiu, H.-M. (2019) · Current Gastroenterology Reports · doi:10.1007/s11894-019-0703-8 · Cited by 208
Duan, S., Huang, W., Liu, X., Liu, X., Chen, N., Xu, Q., Hu, Y., Song, W., & Zhou, J. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0980-3 · Cited by 208
Gut microbiota and colorectal cancer
Gao, R., Gao, Z., Huang, L., & Qin, H. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2881-8 · Cited by 205
Potential Targets for Prevention of Colorectal Cancer: a Focus on PI3K/Akt/mTOR and Wnt Pathways
Pandurangan, A. K. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.4.2201 · Cited by 198
Wei, R., Xiao, Y., Song, Y., Yuan, H., Luo, J., & Xu, W. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1043-0 · Cited by 197
Chen, L.-Y., Wang, L., Ren, Y.-X., Pang, Z., Liu, Y., Sun, X.-D., Tu, J., Zhi, Z., Qin, Y., Sun, L.-N., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01272-9 · Cited by 193
Afrin, S., Giampieri, F., Gasparrini, M., Forbes-Hernández, T. Y., Cianciosi, D., Reboredo-Rodriguez, P., Zhang, J., Manna, P. P., Daglia, M., Atanasov, A. G., et al. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.011 · Cited by 182
Arqués, O., Chicote, I., Puig, I., Tenbaum, S. P., Argilés, G., Dienstmann, R., Fernández, N., Caratù, G., Matito, J., Silberschmidt, D., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3081 · Cited by 178
Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer
Mizuno, R., Kawada, K., & Sakai, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246254 · Cited by 174
Mediterranean diet and colorectal cancer: A systematic review
Farinetti, A., Zurlo, V., Manenti, A., Coppi, F., & Mattioli, A. V. (2017) · Nutrition · doi:10.1016/j.nut.2017.06.008 · Cited by 173
Abualkhair, W. H., Zhou, M., Ahnen, D. J., Yu, Q., Wu, X., & Karlitz, J. J. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.20407 · Cited by 172
Obesity and colorectal cancer: molecular features of adipose tissue
Martinez-Useros, J., & Garcia-Foncillas, J. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0772-5 · Cited by 167
Sanchez-Lopez, E., Flashner-Abramson, E., Shalapour, S., Zhong, Z., Taniguchi, K., Levitzki, A., & Karin, M. (2016) · Oncogene · doi:10.1038/onc.2015.326 · Cited by 162
Polyphenols: Immunomodulatory and Therapeutic Implication in Colorectal Cancer
Mileo, A. M., Nisticò, P., & Miccadei, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00729 · Cited by 160
Xu, Z., Zhu, C., Chen, C., Zong, Y., Feng, H., Liu, D., Feng, W., Zhao, J., & Lu, A. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-1010-2 · Cited by 159
Molecular Basis of Alcohol-Related Gastric and Colon Cancer
Na, H.-K., & Lee, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061116 · Cited by 159
Diallo, A., Deschasaux, M., Latino‐Martel, P., Herçberg, S., Galan, P., Fassier, P., Allès, B., Guéraud, F., Pierre, F. H., & Touvier, M. (2017) · International Journal of Cancer · doi:10.1002/ijc.31046 · Cited by 154
Wnt5a cloning, expression, and up-regulation in human primary breast cancers.
LeJeune, S., Huguet, E., Hamby, A. M., Poulsom, R., & Harris, A. L. (1995) · PubMed · Cited by 152
The Role of PDGFs and PDGFRs in Colorectal Cancer
Manzat-Saplacan, R. M., Bălăcescu, L., Gherman, C. D., Chira, R. I., Anca, C., Mircea, P. A., Lisencu, C. I., & Bălăcescu, O. (2017) · Mediators of Inflammation · doi:10.1155/2017/4708076 · Cited by 151
Turner, N. D., & Lloyd, S. K. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217693117 · Cited by 148
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer
Wang, Q., Shi, Y.-L., Zhou, K., Wang, L.-L., Yan, Z.-X., Liu, Y.-L., Xu, L.-L., Zhao, S.-W., Chu, H.-L., Shi, T.-T., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0776-6 · Cited by 147
la Fuente, M. D., Landskron, G., Parada, D., Dubois‐Camacho, K., Simian, D., Martínez, M., Romero, D., Roa, J. C., Chahuán, I., Gutierrez, R. G. R., et al. (2018) · Tumor Biology · doi:10.1177/1010428318810059 · Cited by 146
Krabbamein í ristli og endaþarmi - yfirlitsgrein
Haraldsdóttir, S., Einarsdóttir, H. M., Smáradóttir, A., Gunnlaugsson, A., Halfdanarson, T. R., & Hálfdánarson, Þ. R. (2014) · Læknablaðið · doi:10.17992/lbl.2014.02.531 · Cited by 146
Ahechu, P., Zozaya, G., Martí, P., Hernández-Lizoáin, J. L., Baixauli, J., Unamuno, X., Frühbeck, G., & Catalán, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02918 · Cited by 142
An Update of Efficacy and Safety of Cetuximab in Metastatic Colorectal Cancer: A Narrative Review
Fornasier, G., Francescon, S., & Baldo, P. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0791-0 · Cited by 134
Sánchez‐Alcoholado, L., Ordóñez, R., Otero, A. P., Plaza-Andrades, I. J., Laborda-Illanes, A., Medina, J. A., Ramos‐Molina, B., Gómez‐Millán, J., & Queipo‐Ortuño, M. I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186782 · Cited by 127
Winder, T., & Lenz, H. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.005 · Cited by 121
Pietrzyk, Ł., Torres, A., Maciejewski, R., & Torres, K. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.10.4161 · Cited by 119
EGFR-mediated macrophage activation promotes colitis-associated tumorigenesis
Hardbower, D. M., Coburn, L. A., Asim, M., Singh, K., Sierra, J. C., Barry, D. P., Gobert, A. P., Piazuelo, M. B., Washington, M. K., & Wilson, K. T. (2017) · Oncogene · doi:10.1038/onc.2017.23 · Cited by 118
miR-150-5p suppresses tumor progression by targeting VEGFA in colorectal cancer
Chen, X., Xu, X., Pan, B., Zeng, K., Xu, M., Liu, X., He, B., Pan, Y., Sun, H., & Wang, S. (2018) · Aging · doi:10.18632/aging.101656 · Cited by 117
Miyamoto, Y., Suyama, K., & Baba, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040752 · Cited by 116
Diet and Colorectal Cancer Risk in Asia - a Systematic Review
Azeem, S., Gillani, S. W., Siddiqui, A. A., Jandrajupalli, S. B., Poh, V., & Sulaiman, S. A. S. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.13.5389 · Cited by 115
Present and future of metastatic colorectal cancer treatment: A review of new candidate targets
Martini, G., Troiani, T., Cardone, C., Vitiello, P. P., Sforza, V., Ciardiello, D., Napolitano, S., Corte, C. M. D., Morgillo, F., Raucci, A., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i26.4675 · Cited by 115
Obesity, diabetes and the risk of colorectal adenoma and cancer
Soltani, G., Poursheikhani, A., Yassi, M., Hayatbakhsh, A., Kerachian, M., & Kerachian, M. A. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0444-6 · Cited by 111
The Growing Challenge of Young Adults With Colorectal Cancer.
Weinberg, B. A., Marshall, J. L., & Salem, M. E. (2017) · PubMed · Cited by 111
Tabernero, J., Cervantes, A., Rivera, F., Martinelli, E., Rojo, F., von Heydebreck, A., Macarulla, T., Rodriguez-Braun, E., Eugenia Vega-Villegas, M., Senger, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.6043 · Cited by 110
Myeloid‐derived suppressor cells: Roles in the tumor microenvironment and tumor radiotherapy
Yin, Z., Li, C., Wang, J., & Xue, L. (2018) · International Journal of Cancer · doi:10.1002/ijc.31744 · Cited by 110
Yarom, N., & Jonker, D. J. (2011) · PubMed · Cited by 110
Custodio, A., & Feliú, J. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.05.001 · Cited by 110
Hallmarks in colorectal cancer: Angiogenesis and cancer stem-like cells
Mathonnet, M., Perraud, A., Christou, N., Akil, H., Mélin, C., Battu, S., Jauberteau, M., & Denizot, Y. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i15.4189 · Cited by 108
Intracrine VEGF signalling mediates colorectal cancer cell migration and invasion
Bhattacharya, R., Fan, F., Wang, R., Ye, X., Xia, L., Boulbés, D. R., & Ellis, L. M. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.238 · Cited by 108
Peters, G., Gongoll, S., Langner, C., Mengel, M., Piso, P., Klempnauer, J. L., Rüschoff, J., Kreipe, H. H., & von Wasielewski, R. (2003) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-003-0856-5 · Cited by 106
HER2: An emerging target in colorectal cancer
Greally, M., Kelly, C. M., & Cercek, A. (2018) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2018.07.001 · Cited by 104
Cancer-associated fibroblasts mediate cancer progression and remodel the tumouroid stroma
Pape, J., Magdeldin, T., Stamati, K., Nyga, A., Loizidou, M., Emberton, M., & Cheema, U. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0973-9 · Cited by 102
Itatani, Y., Yamamoto, T. S., Zhong, C., Molinolo, A., Ruppel, J., Hegde, P. S., Taketo, M. M., & Ferrara, N. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008112117 · Cited by 99
Shaw, E., Farris, M. S., Stone, C. R., Derksen, J. W. G., Johnson, R., Hilsden, R. J., Friedenreich, C. M., & Brenner, D. R. (2018) · BMC Cancer · doi:10.1186/s12885-017-3970-5 · Cited by 94
Balhareth, A., Aldossary, M. Y., & McNamara, D. A. (2019) · World Journal of Surgical Oncology · doi:10.1186/s12957-019-1697-2 · Cited by 93
Obesity, Insulin Resistance, and Colorectal Cancer: Could miRNA Dysregulation Play a Role?
Cirillo, F., Catellani, C., Sartori, C., Lazzeroni, P., Amarri, S., & Street, M. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122922 · Cited by 90
Naringin inhibits colorectal cancer cell growth by repressing the PI3K/AKT/mTOR signaling pathway
Cheng, H., Jiang, X., Zhang, Q., Ma, J., Cheng, R., Yong, H., Shi, H., Zhou, X., Ge, L., & Gao, G. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8649 · Cited by 88
Yao, W., Lin, Z. Y., Shi, P., Chen, B., Wang, G., Huang, J., Sui, Y., Liu, Q., Li, S., Lin, X., et al. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113680 · Cited by 88
Antoniotti, C., Borelli, B., Rossini, D., Pietrantonio, F., Morano, F., Salvatore, L., Lonardi, S., Marmorino, F., Tamberi, S., Corallo, S., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-07169-6 · Cited by 87
Kasprzak, A., & Adamek, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194915 · Cited by 87
Molecular Subtypes and the Evolution of Treatment Decisions in Metastatic Colorectal Cancer
Dienstmann, R., Salazar, R., & Tabernero, J. M. (2018) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_200929 · Cited by 86
Han, Y., Mun, J., Jeon, H. D., Kee, J., & Hong, S. (2019) · Nutrients · doi:10.3390/nu12010066 · Cited by 84
The Tumor Microenvironment in Colorectal Cancer Therapy
Pedrosa, L., Esposito, F. M., Thomson, T. M., & Maurel, J. (2019) · Cancers · doi:10.3390/cancers11081172 · Cited by 82
Smoking-Related Risks of Colorectal Cancer by Anatomical Subsite and Sex
Gram, I. T., Park, S., Wilkens, L. R., Haiman, C. A., & Marchand, L. L. (2020) · American Journal of Epidemiology · doi:10.1093/aje/kwaa005 · Cited by 81
Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer
Codony‐Servat, J., Cuatrecasas, M., Asensio, E., Montironi, C., Martínez‐Cardús, A., Marín‐Aguilera, M., Horndler, C., Martinez‐Balibrea, E., Rubini, M., Jares, P., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.279 · Cited by 79
Ng, K., Tabernero, J. M., Hwang, J. J., Bajetta, E., Sharma, S., Prete, S. A. D., Arrowsmith, E. R., Ryan, D. P., Šedová, M., Jin, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0027 · Cited by 78
Martin, O. C. B., Olier, M., Ellero‐Simatos, S., Naud, N., Dupuy, J., Laurence Therese, H. U. C., Taché, S., Graillot, V., Levêque, M., Bézirard, V., et al. (2019) · Microbiome · doi:10.1186/s40168-019-0685-7 · Cited by 76
Targeted MMP-2 responsive chimeric polymersomes for therapy against colorectal cancer
Ramezani, P., Abnous, K., Taghdisi, S. M., Zahiri, M., Ramezani, M., & Alibolandi, M. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111135 · Cited by 75
Role of VEGF, CD105, and CD31 in the Prognosis of Colorectal Cancer Cases
Mohamed, S. Y., Mohammed, H. L., Ibrahim, H., Mohamed, E. M., & Salah, M. (2017) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-017-0014-y · Cited by 75
Khan, K. H., Valeri, N., Dearman, C., Rao, S., Watkins, D. J., Starling, N., Chau, I., & Cunningham, D. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.09.001 · Cited by 74
Xu, W., Yu, M., Qin, J., Luo, Y., & Zhong, M. (2020) · Cancer Management and Research · doi:10.2147/cmar.s250661 · Cited by 70
Shiratsuchi, I., Akagi, Y., Kawahara, A., Kinugasa, T., Romeo, K., Yoshida, T., Ryu, Y., Gotanda, Y., Kage, M., & Shirouzu, K. (2011) · PubMed · Cited by 70
Diet-Derived Phytochemicals Targeting Colon Cancer Stem Cells and Microbiota in Colorectal Cancer
Ganesan, K., Jayachandran, M., & Xu, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113976 · Cited by 70
Metastatic Colorectal Cancer: Role of Target Therapies and Future Perspectives
Nappi, A. G., Berretta, M., Romano, C., Tafuto, S., Cassata, A., Casaretti, R., Silvestro, L., Divitiis, C. D., Alessandrini, L., Fiorica, F., et al. (2017) · Current Cancer Drug Targets · doi:10.2174/1568009617666170209095143 · Cited by 66
Wanigasooriya, K., Tyler, R., Barros-Silva, J. D., Sinha, Y., Ismail, T., & Beggs, A. D. (2020) · Cancers · doi:10.3390/cancers12051278 · Cited by 65
Martini, G., Ciardiello, D., Vitiello, P. P., Napolitano, S., Cardone, C., Cuomo, A., Troiani, T., Ciardiello, F., & Martinelli, E. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102023 · Cited by 60
Chapkin, R. S., Navarro, S. L., Hullar, M. A. J., & Lampe, J. W. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06106-8 · Cited by 60
Hutchinson, R. A., Adams, R., McArt, D. G., Salto‐Tellez, M., Jasani, B., & Hamilton, P. W. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0531-z · Cited by 60
The p38 MAPK Signaling Activation in Colorectal Cancer upon Therapeutic Treatments
Pranteda, A., Piastra, V., Stramucci, L., Fratantonio, D., & Bossi, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082773 · Cited by 58
Na, S., & Myung, S. (2012) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2012.59.1.16 · Cited by 58
Cornish, A. J., Tomlinson, I. P. M., & Houlston, R. S. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.01.002 · Cited by 56
Garrido‐Laguna, I., Hong, D. S., Jankú, F., Nguyen, L. M., Falchook, G. S., Fu, S., Wheler, J. J., Luthra, R., Naing, A., Wang, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038033 · Cited by 55
Targeted therapy for metastatic colorectal cancer
Price, T. J., Tang, M., Gibbs, P., Haller, D. G., Peeters, M., Arnold, D., Segelov, E., Roy, A. C., Tebbutt, N. C., Pavlakis, N., et al. (2018) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2018.1502664 · Cited by 55
BRG1 promotes VEGF-A expression and angiogenesis in human colorectal cancer cells
Lan, J., Li, H., Luo, X., Hu, J., & Wang, G. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.09.013 · Cited by 54
Li, S., Ung, T. T., Nguyen, T. T., Sah, D. K., Park, S. Y., & Jung, Y. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103420 · Cited by 54
Nobiletin sensitizes colorectal cancer cells to oxaliplatin by PI3K Akt MTOR pathway
Zhang, Z. (2018) · Frontiers in bioscience · doi:10.2741/4719 · Cited by 52
The incidence of young-onset colorectal cancer in Canada continues to increase
O'Sullivan, D. E., Hilsden, R. J., Ruan, Y., Forbes, N., Heitman, S. J., & Brenner, D. R. (2020) · Cancer Epidemiology · doi:10.1016/j.canep.2020.101828 · Cited by 51
Ye, Z., Qiu, M., Tang, T., Wang, F., Zhou, Y., Lei, M., Guan, W., & He, C. (2019) · Cancer Medicine · doi:10.1002/cam4.2727 · Cited by 50
Helmy, M. W., Ghoneim, A. I., Katary, M. A., & Elmahdy, R. K. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05327-4 · Cited by 49
Simulated Microgravity Influences VEGF, MAPK, and PAM Signaling in Prostate Cancer Cells
Hybel, T. E., Dietrichs, D., Sahana, J., Corydon, T. J., Nassef, M. Z., Wehland, M., Krüger, M., Magnusson, N. E., Bauer, J. W., Utpatel, K., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041263 · Cited by 49
Su, M., Zhao, J., Yan, X., Li, J., & Zhang, R. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10510 · Cited by 49
Mola, S., Pandolfo, C., Sica, A., & Porta, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186866 · Cited by 48
Hosseini, S. A., Zand, H., & Cheraghpour, M. (2019) · Medicina · doi:10.3390/medicina55040090 · Cited by 48
IGF1R and c-met as therapeutic targets for colorectal cancer
Shali, H., Ahmadi, M., Kafil, H. S., Dorosti, A., & Yousefi, M. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.05.034 · Cited by 46
Canavese, M., Ngo, D. T. M., Maddern, G. J., Hardingham, J. E., Price, T. J., & Hauben, E. (2016) · International Journal of Cancer · doi:10.1002/ijc.30567 · Cited by 46
Mediterranean diet adherence and risk of colorectal cancer: the prospective Netherlands Cohort Study
Schulpen, M., & van den Brandt, P. A. (2019) · European Journal of Epidemiology · doi:10.1007/s10654-019-00549-8 · Cited by 46
Ganesan, P., Jankú, F., Naing, A., Hong, D. S., Tsimberidou, A. M., Falchook, G. S., Wheler, J. J., Piha-Paul, S. A., Fu, S., Stepanek, V. M. T., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0319-t · Cited by 45
Wang, J., Dong, L., Zhang, X., He, C., Cao, L., Zhang, S., Xiao, X., Li, S., & Cao, Y. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5151 · Cited by 44
Epidermal Growth Factor Receptor Pathway Mutations and Colorectal Cancer Therapy
Grossmann, A. H., & Samowitz, W. S. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0047-ra · Cited by 43
Simultaneous Detection of EGFR and VEGF in Colorectal Cancer using Fluorescence-Raman Endoscopy
Kim, Y.-I., Jeong, S., Jung, K. O., Song, M. G., Lee, C., Chung, S., Park, J. Y., Cha, M. G., Lee, S. G., Jun, B., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01020-y · Cited by 42
Wagner, J., Kline, C. L. B., Zhou, L., Khazak, V., & El‐Deiry, W. S. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0671-0 · Cited by 41
Progress in Research on Colorectal Cancer-Related Microorganisms and Metabolites
Han, S., Jing, Z., Wu, Y., Wu, W., & Yang, X. (2020) · Cancer Management and Research · doi:10.2147/cmar.s268943 · Cited by 40
Napolitano, S., Matrone, N., Muddassir, A. L., Martini, G., Sorokin, A., De Falco, V., Giunta, E. F., Ciardiello, D., Martinelli, E., Belli, V., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1497-0 · Cited by 40
Cross-talk between non-coding RNAs and PI3K/AKT/mTOR pathway in colorectal cancer
Moafian, Z., Maghrouni, A., Soltani, A., & Hashemy, S. I. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06458-y · Cited by 40
Possible roles of insulin, IGF-1 and IGFBPs in initiation and progression of colorectal cancer
Jiang, B. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i6.1608 · Cited by 39
Mutations of the APC Gene in Human Sporadic Colorectal Cancers
Filippo, C. D., Luceri, C., Caderni, G., Pacini, M., Messerini, L., Biggeri, A., Mini, E., Tonelli, F., Cianchi, F., & Dolara, P. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202320378248 · Cited by 37
Damato, A., Iachetta, F., Antonuzzo, L., Nasti, G., Bergamo, F., Bordonaro, R., Maiello, E., Zaniboni, A., Tonini, G., Romagnani, A., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-07268-4 · Cited by 34
Wei, H., Dong, C., & Shen, Z. (2020) · Neoplasma · doi:10.4149/neo_2020_190814n758 · Cited by 33
Insights into the Role of microRNAs in Colorectal Cancer (CRC) Metabolism
Hon, K. W., Abidin, S. A. Z., Othman, I., & Naidu, R. (2020) · Cancers · doi:10.3390/cancers12092462 · Cited by 33
Brummelen, E. M. J., Huijberts, S., Herpen, C., Desar, I., Opdam, F., Geel, R., Marchetti, S., Steeghs, N., Monkhorst, K., Thijssen, B., et al. (2021) · The Oncologist · doi:10.1002/onco.13631 · Cited by 32
MicroRNA‑125 inhibits RKO colorectal cancer cell growth by targeting VEGF
Wu, Q., Chen, J., Zhu, J., Yin, X. H., You, H., Lin, Y., & Zhu, H. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3632 · Cited by 32
Abdalla, A. N., Malki, W. H., Qattan, A. T., Shahid, I., Hossain, M. A., & Ahmed, M. (2021) · Molecules · doi:10.3390/molecules26020334 · Cited by 31
Daveri, E., Adamo, A. M., Alfine, E., Zhu, W., & Oteiza, P. I. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101830 · Cited by 30
Marisi, G., Scarpi, E., Passardi, A., Nanni, O., Ragazzini, A., Valgiusti, M., Gardini, A. C., Neri, L. M., Frassineti, G. L., Amadori, D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01420-0 · Cited by 29
Relation of the IGF/IGF1R system to autophagy in colitis and colorectal cancer
Sípos, F., Székely, H., Kis, I. D., Tulassay, Z., & Műzes, G. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i46.8109 · Cited by 29
Effects of high‐fat diet‐induced adipokines and cytokines on colorectal cancer development
Zhang, J., Guo, S., Li, J., Bao, W., Zhang, P., Huang, Y., Ling, P., Wang, Y., & Zhao, Q. S. (2019) · FEBS Open Bio · doi:10.1002/2211-5463.12751 · Cited by 28
Determination of IL-6, TNF-α and VEGF levels in the serums of patients with colorectal cancer
Coşkun, Í., í–ztopuz, Í., & í–zkan, Í. F. (2017) · Cellular and Molecular Biology · doi:10.14715/cmb/2017.63.5.18 · Cited by 28
Wang, S. Q., Yang, X. Y., Cui, S. X., Gao, Z. H., & Qu, X. J. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.12.035 · Cited by 27
Dinami, R., Porru, M., Amoreo, C. A., Sperduti, I., Mottolese, M., Buglioni, S., Marinelli, D., Maugeri‐Saccà, M., Sacconi, A., Blandino, G., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01612-z · Cited by 27
Ekine-Afolabi, B. A., Njan, A. A., Rotimi, S. O., I, A. R., Elbehi, M. A., Cash, E. D., & Adeyeye, A. A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.583372 · Cited by 27
Folprecht, G., Tabernero, J. M., Köhne, C., Zacharchuk, C., Paz-Ares, L. G., Rojo, F., Quinn, S., Casado, E., Salazar, R., Abbas, R., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1053 · Cited by 27
Kyriakopoulos, C. E., Braden, A. M., Kolesar, J., Eickhoff, J. C., Bailey, H. H., Heideman, J. L., Liu, G., & Wisinski, K. B. (2016) · Investigational New Drugs · doi:10.1007/s10637-016-0418-8 · Cited by 25
Li, S., Wang, X., Wang, G., Shi, P., Lin, S., Xu, D., Chen, B., Liu, A., Huang, L., Lin, X., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.565090 · Cited by 25
Cyclical Treatment of Colorectal Tumor Spheroids Induces Resistance to MEK Inhibitors
Thakuri, P. S., Luker, G. D., & Tavana, H. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.11.009 · Cited by 24
VEGF Gene Polymorphisms and Susceptibility to Colorectal Cancer
Jannuzzi, A. T., Özhan, G., Yanar, H. T., & Alpertunga, B. (2015) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2014.0259 · Cited by 24
Joshi, P., Joshi, R. K., Kim, W. J., & Lee, S. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.9.3735 · Cited by 21
Vitamin D and the insulin‐like growth factor system: Implications for colorectal neoplasia
Ciulei, G., Orasan, O. H., Coste, S. C., Cozma, A., Negrean, V., & Procopciuc, L. M. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13265 · Cited by 21
Yun, S., Kwak, Y., Nam, S. K., Seo, A. N., Oh, H., Kim, D., Kang, S., & Lee, H. S. (2018) · Cancer Research and Treatment · doi:10.4143/crt.2017.487 · Cited by 19
Wojtukiewicz, M. Z., Mysliwiec, M., Sierko, E., Sobierska, M., Kruszewska, J., Lipska, A., Radziwon, P., Tucker, S. C., & Honn, K. V. (2020) · Pathology & Oncology Research · doi:10.1007/s12253-020-00854-8 · Cited by 19
Detecting APC Gene Mutations in Familial Adenomatous Polyposis (FAP)
Nallamilli, B. R. R., & Hegde, M. (2017) · Current Protocols in Human Genetics · doi:10.1002/cphg.29 · Cited by 19
Jeong, M. A., & Kang, H. W. (2019) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2019.74.1.4 · Cited by 19
MiR-10b suppresses the growth and metastasis of colorectal cancer cell by targeting FGF13.
Jj, S., & Li, W. (2019) · PubMed · doi:10.26355/eurrev_201901_16870 · Cited by 19
Advances in insulin-like growth factor biology and -directed cancer therapeutics
Fettig, L. M., & Yee, D. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2020.04.005 · Cited by 19
Current and future targets and therapies in metastatic colorectal cancer.
Džunić, M., Petković, I., Cvetanović, A., Vrbić, S., & Pejcic, I. (2019) · PubMed · Cited by 17
Novel strategies for comprehensive mutation screening of the APC gene
Wachsmannová, L., Mego, M., Števurková, V., Zajac, V., & Čierniková, S. (2017) · Neoplasma · doi:10.4149/neo_2017_303 · Cited by 17
Increased expression of IGF-1Ec with increasing colonic polyp dysplasia and colorectal cancer
Alagaratnam, S., Loizidou, M., Yang, S., Fuller, B. J., & Ramesh, B. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03345-0 · Cited by 17
Miyamoto, Y., Muguruma, N., Fujimoto, S., Okada, Y., Kida, Y., Nakamura, F., Tanaka, K., Nakagawa, T., Kitamura, S., Okamoto, K., et al. (2019) · Cancer Science · doi:10.1111/cas.14020 · Cited by 17
Epidermal growth factor receptor-targeted therapy in colorectal cancer
Xu, W. (2015) · Frontiers in bioscience · doi:10.2741/4397 · Cited by 16
Epidermal growth factor receptor and metastatic colorectal cancer: Insights into target therapies
de Mello, R. A., Marques, A. M., & Araújo, A. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i38.6315 · Cited by 16
An examination between census tract unhealthy food availability and colorectal cancer incidence
Gibson, D. C., Prochaska, J. D., Yu, X., & Kaul, S. (2020) · Cancer Epidemiology · doi:10.1016/j.canep.2020.101761 · Cited by 16
Hu, J., Liu, X., Chi, J., Che, K., Feng, Y., Zhao, S., Wang, Z., & Wang, Y. (2018) · Cancer Biomarkers · doi:10.3233/cbm-170942 · Cited by 15
Fruquintinib and its Use in the Treatment of Metastatic Colorectal Cancer
Deng, Y., & Li, X. (2019) · Future Oncology · doi:10.2217/fon-2018-0454 · Cited by 15
Hu, X., Zheng, W., Luo, Y., Ou, X., Song, L., Zhang, S., He, T., Guo, Z., Zhu, J., Shi, H. R., et al. (2019) · Nutrition and Cancer · doi:10.1080/01635581.2019.1625935 · Cited by 14
Armengol, G., Sarhadi, V. K., Ghanbari, R., Doghaei-Moghaddam, M., Ansari, R., Sotoudeh, M., Puolakkainen, P. A., Kokkola, A., Malekzadeh, R., & Knuutila, S. (2016) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2016.01.008 · Cited by 14
Foroughi, S., Tie, J., Gibbs, P., & Burgess, A. W. (2019) · Growth Factors · doi:10.1080/08977194.2019.1703702 · Cited by 13
Karpuz, T., Araz, M., Korkmaz, L., Kılınç, İ., Fındık, S., Karaağaç, M., Eryılmaz, M. K., & Artaç, M. (2019) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-019-00263-4 · Cited by 13
D’Haene, N., Koopmansch, C., Eycke, Y. V., Hulet, F., Allard, J., Bouri, S., Rorive, S., Remmelink, M., Decaestecker, C., Maris, C., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113536 · Cited by 13
Herichová, I., Reis, R. D. F., Hasakova, K., Vician, M., & Zeman, M. (2019) · Physiological Research · doi:10.33549/physiolres.934352 · Cited by 10
Weinberg, B. A., Hartley, M. L., & Salem, M. E. (2017) · PubMed · Cited by 10
Wang, D., Zhang, Z., Li, Y., Xu, C., Yu, Y., Li, M., Chen, C., & Zhang, X. (2019) · Medical Science Monitor · doi:10.12659/msm.913911 · Cited by 9
Awareness of health sciences students about colorectal cancer risk factors
Üstündağ, H., Zengin, N., Andsoy, I. I., & Gül, A. (2019) · European Journal of Cancer Care · doi:10.1111/ecc.13016 · Cited by 9
Correlation of human epidermal growth factor receptor protein expression and colorectal cancer
Yang, W., Shen, X.-J., Ma, X.-X., Tan, Z.-G., Song, Y., Guo, Y.-T., & Yuan, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i28.8687 · Cited by 8
Mo, H. Y., Lee, J. H., Kim, M. S., Yoo, N. J., & Lee, S. H. (2019) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000777 · Cited by 7
Rising Incidence of Colorectal Cancer in Patients Younger than Age 50 in Hawai'i.
Jain, A., & Jain, S. (2019) · PubMed · Cited by 6
Jung, Y. S., Kim, N. H., Yang, H., Park, S., Park, J. H., Park, D. I., & Sohn, C. I. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14023 · Cited by 5
[Increasing incidence of colorectal cancer in young patients].
Cai, L., Bennedsen, A. L. B., Qvortrup, C., & Gögenür, I. (2019) · PubMed · Cited by 5
[Detection of KRAS gene mutations in colorectal carcinoma: a study of 6 364 patients].
Wang, D., Wang, L., Duan, X., Liu, L., Shen, H., Peng, Y., & Li, B. (2014) · PubMed · Cited by 3
Epidermal Growth Factor Receptor Expression of Colorectal Carcinoma in Nigerian Patients.
Lawan, A. I., & Ogunbiyi, O. J. (2020) · PubMed · Cited by 3
Nemanqani, D. M., Aftab, K., Almalki, S. H., & Al-Sufyani, W. M. (2018) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2018.07.527 · Cited by 1
Research works printed but not linked: 1
- Haraldsdottir, 2014, Colorectal cancer—Review, Laeknabladid, 100, 75
Cited by
Targeting the EGFR signaling pathway in cancer therapy: What’s new in 2023?
Halder, S., Basu, S., Lall, S. P., Ganti, A. K., Batra, S. K., & Seshacharyulu, P. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2218613 · Cited by 133
“AKT/mTOR signaling that supports tumor cell survival, growth, and invasion [8].”
BackgroundCasado, M. E., Collado‐Perez, R., Frago, L. M., & Barrios, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021422 · Cited by 134
“Abnormal activation of this molecule due to changes in the levels of specific interleukins and growth factors is associated with the appearance of cancer [50].”
BackgroundThe Role of Curcumin in Cancer: A Focus on the PI3K/Akt Pathway
Zoi, V., Kyritsis, A. P., Galani, V., Lazari, D. M., Sioka, C., Voulgaris, S., & Alexiou, G. Α. (2024) · Cancers · doi:10.3390/cancers16081554 · Cited by 119
“…inactivation of the tumor suppressor gene PTEN, and the overexpression of growth factors—such as vascular endothelial growth factor-A (VEGF-A), platelet-derived growth factor (PDGF), or epidermal growth factor (EGF)—are primarily responsible for the dysregulation of the PI3K/Akt pathway [8,9].”
BackgroundZhou, Y., Zhang, W., Wang, B., Wang, P., Li, D., Cao, T., Zhang, D., Han, H., Bai, M., Wang, X., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-008054 · Cited by 107
“As a clinically applicable drug, decitabine shows great potential for promoting pyroptosis in tumors with low endogenous GSDME expression on IR700DX- 6T-PDT treatment.”
BackgroundFerraguti, G., Terracina, S. A., Petrella, C., Greco, A., Minni, A., Lucarelli, M., Agostinelli, E., Ralli, M., VINCENTIIS, M. D., Raponi, G., et al. (2022) · Antioxidants · doi:10.3390/antiox11010145 · Cited by 106
Metadata
- Authors
- Stefani, C., Miricescu, D., Stanescu-Spinu, I.-I., Nica, R. I., Greabu, M., Totan, A. R., & Jinga, M.
- Affiliations
- Department of Family Medicine and Clinical Base, ‘‘Dr. Carol Davila’ Central Military Emergency University Hospital, 051075 Bucharest, Romania
- Carol Davila University of Medicine and Pharmacy (RO)
- Department of Biochemistry, Faculty of Dental Medicine, Carol Davila University of Medicine and Pharmacy, 8 Eroii Sanitari Blvd, 050474 Bucharest, Romania
- Spitalul Universitar de Urgenţă Militar Central Dr. Carol Davila (RO)
- Corresponding author
- Miricescu, Daniela
- Greabu, Maria
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-09-23
- Volume
- 22
- Issue
- 19
- Pages
- 10260
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8508474
- OpenAlex
- W3200117713
- Cited by
- 402
- References
- 206
- Citations by year
- 2026: 69 · 2025: 134 · 2024: 103 · 2023: 68 · 2022: 26 · 2021: 2
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- colorectal cancer, growth factors, PI3K/AKT/mTOR pathway, MAPK signaling, tumor microenvironment, EGFR, IGF-1 receptor, VEGF-A, growth factor inhibitors, colorectal cancer risk factors, colorectal cancer pathogenesis, cell proliferation and invasion
- MeSH terms
- Animals, Humans, Colorectal Neoplasms, Signal Transduction, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinases, Intercellular Signaling Peptides and Proteins, Proto-Oncogene Proteins c-akt, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

